Sunday, October 21, 2018

Analysts tell health advocates that Medicaid budget 'shortfall' described by state officials is premature

By Melissa Patrick
Kentucky Health News

The warning from the administration of Republican Gov. Matt Bevin that some Medicaid benefits may need to be cut because of a budget shortfall over the next two fiscal years has caused unnecessary alarm, a research and policy analyst for the Kentucky Center for Economic Policy, said at the Kentucky Voices for Health annual meeting in Lexington Oct. 19.

Analysts Jason Dunn and Dustin Pugel
gave an update on health policy at the
Kentucky Voices for Health meeting.
Dustin Pugel referred to a presentation the Cabinet for Health and Family Services made in August to the legislature's Budget Review Subcommittee on Human Resources, predicting that over the next two fiscal years the state will be $300 million short in what it needs to pay for Medicaid.

"There's some problems with their math," Pugel said.

He said the cabinet based its estimate on its initial forecast of expenses, though there is almost always a gap between what an agency requests and what the legislature puts in the budget.

"To call that a shortfall is strange," Pugel said. "And if, in fact, you add up all of the agency requests in the entire budget versus what was enacted, then we would say that we have a $2 billion shortfall in the general fund, which of course we don't." He said the projected "shortfall" would be only 1 percent of the state's total budget.

Medicaid is a joint state and federal health insurance program that spends about $11.5 billion a year to cover 1.4 million Kentuckians, nearly one in three. Before its expansion under the Patient Protection and Affordable Care Act in 2014, by Democratic Gov. Steve Beshear, the program was mainly limited to very poor pregnant women and children, disabled people and low-income elderly in nursing homes.

Asked in September to respond to the KCEP report on this topic, cabinet spokesman Doug Hogan said cabinet officials explained to the legislators that their overall concern is about a shortfall in the state's General Fund because the state must have money in the fund to get federal matching money.

"The state General Fund shortfall is 6.61 percent in FY19 and 5.61 percent in FY20," Hogan said in an e-mail. "This is significantly more than 1 percent, and not easy to adapt to, since Medicaid spending is primarily driven by two things: (1) the number of eligibles and (2) benefits costs, much of which are mandatorily required under federal law."

Pugel said the cabinet's own data shows that benefit costs and Medicaid enrollment are declining, which "should indicate that Medicaid expenditures will come in under the initial expectation."

Pugel told the roomful of health advocates that the cabinet's proposed solution to this "shortfall" is to eliminate dental, vision and pharmacy benefits to those on Medicaid, or even to end the expansion of the program to those who earn up to 138 percent of the federal poverty level. The expansion added about 500,000 people to the Medicaid rolls.

"Even if it were true, we have a lot of time," Pugel said. "We've got a fiscal year and a half to be able to figure this out and there's really not a lot of cause for alarm -- and alarm in this case would be threatening to remove very important benefits."

The center's report adds that the cabinet failed to explain the context for the projected shortfall and ignored additional resources that were already appropriated to deal with some of the costs.

For example, the report says the cabinet's shortfall spreadsheet includes higher fees for dispensing drugs and increases in the Supports for Community Living and Traumatic Brain Injury programs without showing that $91 million was appropriated to offset those costs.

Hogan said the cabinet did not "ignore" those resources. He wrote, "This demonstrates that KCEP does not understand or chooses to ignore CHFS testimony about how the shortfall was projected, which was to take the Consensus Forecast Group projection, add additional costs not anticipated by CFG that occurred after CFG made projection, and then look at the difference in the enacted budget amount."

Asked about this, Pugel held to his center's claim. "To add those as additional costs without any indication that they are also paid for is erroneous," Pugel said in an e-mail. He added that the financial director tried to make this point clear at one point in the meeting, "but it was a short explanation and the point didn't come across to the lawmakers."

Hogan wrote, "KCEP is an agenda driven left leaning organization that inaccurately interprets data to support its narrative. KCEP lives in a fictional land where money and resources are unlimited and solutions typically involve simply throwing more money at whatever issue they are looking at that particular day, while ignoring that the money must come from somewhere else."

UK gets $15 million grant to treat 900 drug users with hepatitis C in Hazard area to examine concept of 'treatment as prevention'

By Melissa Patrick
Kentucky Health News

The University of Kentucky has received a five year, $15 million grant along with a $50 million donation in drugs, to treat hepatitis C in Hazard and Perry County in order to examine the concept of "treatment as prevention."

Hepatitis C is a contagious liver disease caused by a virus that is primarily spread by injection drug users when they share needles or other equipment. Left untreated, it can lead to cirrhosis or liver cancer.

Jennifer Havens
The Kentucky Viral Hepatitis Treatment Project, led by Jennifer Havens at the UK Center on Drug and Alcohol Research, will provide treatment to 900 Perry County drug users who have hepatitis C. They have already been identified through Havens' previous work in the county around drug addiction.

Havens told the UK Board of Trustees, at a day-long meeting devoted to the issues of opioid abuse, that it's important to treat people who test positive for hepatitis C in drug-using networks as a way to prevent its transmission.

"Once they are cured, they are no longer transmitting," she said Thursday. "So it makes a whole lot of sense to use this treatment-as-prevention approach. It lowers the community viral load."

Havens said the project's goal is to increase access to hepatitis C treatment in rural Appalachia by removing the barriers to care, such as cost, insurance restrictions and poor access to specialists.

The project will also cover the cost of substance-use disorder treatment for each of the participants and a case manager to help with any additional barriers to care, such as transportation. It will also cover the cost of the Perry County Health Department's syringe exchange during the study period.

Havens said the treatment will reduce the future health-care burden in a region that already has such vast health disparities. Ultimately, she said she plans to use the evidence gathered from the research to build new models of hepatitis C care across the nation.

Funding for the project comes from the National Cancer Institute and the National Institute on Drug Abuse. Also, Gilead Sciences Inc. will donate 900 doses of the costly hepatitis C anti-viral drug, valued at $50 million.

Saturday, October 20, 2018

As the FDA plans to approve sale of a super-strong painkiller, a Kentucky doctor with authority in the field objects

By Al Cross
Kentucky Health News

A Kentucky doctor with expertise in the field is objecting to the Food and Drug Administration's plan to approve for sale a painkiller stronger than fentanyl, an opioid that is deadly even in very small doses.

Dr. Raeford Brown
Dr. Raeford Brown, a professor of anesthesiology and pediatrics at the University of Kentucky, is the longtime chair of the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee. The panel voted 10-3 on Oct. 12 to support approval of a form of sufentanil branded as Dsuvia. Brown said he was unable to attend that meeting, but sent the panel a statement saying why sufentanil "represents a danger to the general public health and will make our job of protecting Americans more difficult." He explained the reasons for his opinion:

"Once the FDA approves an opioid compound, there are no safeguards as to the population that will be exposed, the post-marketing analysis of prescribing behavior, or the ongoing analysis of the risks of the drug to the general population relative to its benefit to the public health. Briefly stated, for all of the opioids that have been marketed in the last 10 years, there has not been sufficient demonstration of safety, nor has there been post-marketing assessment of who is taking the drug, how often prescribing is inappropriate, and whether there was ever a reason to risk the health of the general population by having one more opioid on the market."

Because sufentanil is so potent, it is given in "quite small" doses and easy to divert to illegal use, Brown warned. "I predict that we will encounter diversion, abuse, and death within the early months of its availability on the market." Sufentanil is 500 times stronger than morphine.

The FDA says it can require the drug to be used only in "closely controlled settings," Brown wrote, but "In order to have this happen, the education of all prescribers would need to be guaranteed. This has not been demonstrated with any other opioid, and, given the lack of teeth in the current risk evaluation and mitigation strategies for opioids, there is currently no educational nor regulatory scheme that will guarantee that this drug will be used only as described in the label."

Brown's statement was part of a letter from the nonprofit public-interest group Public Citizen that criticized the FDA for not having its full Drug Safety and Risk Management Advisory Committee participate in the meeting of his committee, "predictably increasing the odds of a vote favoring FDA approval." The letter also said the FDA made "an unrealistic and dangerous decision . . . that the two major safety problems causing the agency to reject sublingual sufentanil tablets in 2017 were no longer a barrier to its approval and that the benefits thereby outweigh the risks."

Dsuvia’s manufacturer, AcelRx Pharmaceuticals Inc., says its 30-microgram tablets are no stronger than any other opioid already available in the U.S. It says the design makes it easier for use on a battlefield, "and could help elderly or obese patients, for whom an intravenous opioid can be difficult and oral opioids take some time to start working," Emma Court of Marketwatch reports.

Medicare open enrollment runs through Dec. 7; here's more advice, including a book by a former Kentucky business editor

"For those approaching Medicare or already covered by it, now is a critical time of year to review health benefits," Sally Squires writes for The Washington Post. "Several changes are coming in 2019, including to Medicare Part D drug coverage insurance and to some Medicare Advantage plans, which are offered by private insurance companies and are known as Medicare Part C."

So, it seems "more important than ever for Medicare recipients — and anyone approaching age 65 — to begin looking at all the details right now, during Medicare’s open enrollment period, which began Oct. 15 and ends Dec. 7," Squires writes. "This is the prime time of year when changes can be made in a plan without penalty. There are a lot of different plans that can work better or worse depending on your health status and finances. Experts say you should choose a plan that will not just take care of your health needs today but also what they could be in 10 years."

One such expert is Philip Moeller, a former business editor of the Louisville Courier Journal, who is the author of a popular book, Get What’s Yours for Medicare: Maximize Your Coverage, Minimize Your Costs, which Squires notes.

Squires details some important elements of Medicare, such as Part A, "which covers inpatient hospital care, short-term care in a skilled nursing facility, hospice care and some in-home care." Most people pay no Part A premiums because they Medicare taxes have been deducted from their paychecks for at least 10. "Part B premiums range from about $134 per person per month to $429 per month for those earning about $160,000 as an individual or more than $320,000 for a joint tax return," Squires notes. "The cost of Part C Medicare Advantage plans varies by the company offering the plans and benefits covered." And look carefully at those plans, beyond premiums to deductibles and co-payments, advises Trudy Lieberman of the Rural Health News Service.

Also, it's important to remember that "Medicare covers most, but not all, costs," Squires writes. "For 2018, the Part A deductible that a patient must cover is $1,340 for each hospital admission during the year. For extended hospitals stays beyond 61 days, there are additional costs of at least $335 per day that recipients pay."

Friday, October 19, 2018

Parent firm of KentuckyOne Health gets conditional approval from Catholic Church to merge with San Francisco's Dignity Health

The parent firm of most Catholic-owned hospitals in Kentucky, Catholic Health Initiatives, has received conditional approval from church officials to merge with Dignity Health, a not-for-profit chain based in San Francisco.

The deal "would create the nation's largest not-for-profit hospital company by revenue," Harris Meyer and Tara Bannow report for Modern Healthcare. CHI's Kentucky facilities, operating under the name KentuckyOne Health, include Louisville's Jewish Hospital and its affiliatesSt. Joseph Hospital in Lexington, London, Martin, Mount Sterling and Nicholasville; Flaget Memorial Hospital in Bardstown, Our Lady of Peace in Louisville; and Sts. Mary and Elizabeth Hospital in Louisville.

After the church's Congregation for the Doctrine of Faith deferred to local bishops, Denver Archbishop Samuel Aquila told CHI "that as long as his five moral conditions for the deal continue to be met, he had no moral objections to the merger going forward," as long as the merged chain had a recognizably Catholic name and other relatively minor conditions, Modern Healthcare reports.

"While the archbishops of Denver and San Francisco, where CHI and Dignity, respectively, are headquartered, previously had signed off on the so-called ministry alignment agreement, their approval was dependent on Vatican approval, which was uncertain," Meyer and Bannow report. "That left a cloud over the plan, initially announced in 2016, to create a combined system with 139 hospitals in 28 states with total annual revenue of nearly $30 billion."

The National Catholic Bioethics Center had given the merger "an unfavorable moral analysis . . . which added to the uncertainty about the Vatican's decision. CHI and Dignity then sought additional moral analyses from three other ethicists, who gave favorable opinions," the reporters write. "The merger still needs approval from state regulators in California, Arizona and Colorado, CHI's chief financial officer, Dean Swindle, said on an Oct. 11 call with investors."

California Attorney General Xavier Becerra is facing pressure "to ensure that the deal does not limit reproductive health services, care for LGBTQ patients, or services for low-income and under-served communities," Meyer and Barrow report. "Fifteen of Dignity's 39 hospitals are historically non-Catholic and provide services that are prohibited under Catholic doctrine, forcing the dealmakers to craft a merger model that worked around the directives." It would allow Dignity's non-Catholic hospitals to keep doing services the church considers immoral, such as tubal ligations after deliveries.

UPDATE, Nov. 23: Becerra approved the deal with conditions, including continuation of emergency services and women's health-care services at the California hospitals for 10 years. The merged firm will be CommonSpirit Health, Modern Healthcare reports.

Wednesday, October 17, 2018

UK Rural and Underserved Health Research Center symposium Nov. 12; topics include opioids, vaccines, hospitals, miners' health

The Rural and Underserved Health Research Center is holding a free half-day symposium to discuss research in a wide range of topics, including: rural opioid misuse and suicide, pneumonia-vaccine disparities, the impact of rural hospital closures on emergency services, and health-care utilization among coal miners with black lung and other respiratory diseases.

The symposium will be held at the University of Kentucky Gatton Student Center, Senate Chamber A268, from 9 a.m. to 11 a.m. Nov. 12. The event is free, but registration is required before Nov. 5. Click here to register. Click here to see the full agenda.

The RUHRC is a grant-funded program that focuses its research on access to healthcare and substance abuse treatment in underserved rural areas of the United States, including Appalachia. The research is meant to better inform health policy makers "with the ultimate goal of reducing inequities in care and improving population health in rural communities," says its website.

Tuesday, October 16, 2018

Ky. Rural Health Association's annual conference to be held in Bowling Green Nov. 15-16; registration prices go up Nov. 2

The 20th annual conference of the Kentucky Rural Health Association will be held in Bowling Green Nov. 15-16 at Western Kentucky University's Knicely Conference Center, 2355 Nashville Rd. Through Thursday, Nov. 1, the registration fee is $125 for KRHA members and $175 for non-members. After Nov. 1, the fees are $175 and $225, respectively. Student rates are $45 and $55, respectively. For detailed registration information, click here. For a copy the agenda and other information, click here.

Monday, October 15, 2018

E-cig conference in Louisville Dec. 10; FDA says crackdown on teen sales may impede usage by adults who want to quit smoking

Amid growing concerns that electronic cigarettes will undermine the progress made in reducing tobacco-related disease in Kentucky, the Coalition for a Smoke-Free Tomorrow will host a half-day conference Dec. 10 in Louisville to explore the latest evidence about the health effects of e-cigarettes.

Getty Images
The Foundation for a Healthy Kentucky and Kentucky Youth Advocates will also release a new focus group report that day about Kentucky youth attitudes and perceptions about e-cigs.

"E-cigarette use among youth is at now at epidemic levels, escalating dramatically since the introduction of flavored pod e-cigarettes such as Juul and copycat products," Ben Chandler, chair of the coalition and CEO of the foundation, said in a news release. "Kentucky lawmakers and health advocates need to know what the research says about these products, and how they're impacting future tobacco use and health. We'll also examine the policies that should be enacted to turn back this alarming new trajectory."

Speakers at the conference, titled "Next Generation Tobacco: The Impact of E-Cigarettes on Kentucky's Future Health," will discuss who's using e-cigarettes and other electronic nicotine delivery systems in Kentucky, and potential policies for preventing associated disease and illness.

Speakers will focus on the role of flavors in encouraging underage vaping; the extent to which e-cigarettes and other vaping devices actually help people quit smoking; what's in vaping products; whether they are a safer alternative to combustible cigarettes; and the evidence that e-cigs are a gateway to smoking for youth and young adults.

The conference will be held Monday, Dec. 10, from 8:30 a.m. to 12:15 p.m. at the foundation office, 1640 Lyndon Farm Court, in Louisville. Remote viewing sites will be announced later this month. The conference is free, but registration is required. Click here to register and to see the full agenda.

The announcement of the conference is timely.

On Oct. 12, the U.S. Food and Drug Administration sent warning letters to 21 e-cigarette companies seeking information about whether more than 40 products, including some flavored e-cig products, are being illegally marketed or are outside the agency's compliance policies, according to an agency news release.

This is the FDA's latest effort to stop the illegal sale of e-cigs to youth and decrease the "kid-friendly marketing and appeal of these products," it notes. In recent months, the agency has sent more than 1,300 warning letters and fines to retailers for illegally selling e-cigs to minors; given major e-cig makers 60 days to submit plans to address youth access and use; adjusted compliance policies; and launched a new anti-vaping advertising campaign aimed at teens called "The Real Cost."

"The FDA remains committed to the potential opportunity for e-cigarettes to help adult smokers transition away from combustible cigarettes. But we cannot allow that opportunity to come at the expense of addicting a whole new generation of kids to nicotine," Dr. Scott Gottlieb, the FDA commissioner, said in the release.

He added, "We’ll take forceful steps to stem the youth use, even if our actions have the unwelcome effect of impeding some opportunities for adults. These are the hard tradeoffs we now need to make."

Sunday, October 14, 2018

Flu season is here, and Kentucky has already seen one death from it; health officials urge all 6 months and older to get a shot

By Melissa Patrick
Kentucky Health News

The 2018-19 flu season has barely started, but Kentucky has already reported its first flu-related death -- in Lexington, according to the Lexington-Fayette County Health Department. The flu killed 325 people in Kentucky in the last flu season.

Flu is a very contagious disease caused by the influenza virus that spreads from person to person. Symptoms include fever, headache, cough, sore throat, runny nose, sneezing and body aches.

An antiviral drug can shorten the course of the illness or reduce its severity if given within two days of a person getting the flu, but there is no real treatment for the disease, and that's why health officials encourage everyone six months and older to get a flu shot.

"There's no treatment for the flu," Dr. Ryan Stanton, a Lexington emergency-room physician, told WKYT-TV. "Our only fight against this is prevention."

KHN Editor Al Cross's bandage after
his flu shot. (Photo by Patti Cross)
Concern that the state will experience another flu epidemic like last season has prompted a statewide "Focus on Flu" campaign to encourage Kentuckians to get their flu shot. The campaign is being led by doctors, health agencies and the Foundation for a Healthy Kentucky. Their message: "Get your shot! Consult your doc! Stop the spread!"

And it's a message for sharing. Kentucky ranks 33rd in the nation for the number of people who get a flu shot, and at the campaign's kick-off rally in September, it was reported that only 40 percent of Kentuckians got a flu shot last flu season.

And while a flu shot won't guarantee that a person won't get infected, the U.S. Centers for Disease Control and Prevention says it will reduce the risk of infection by 40 to 60 percent, and it has been shown to reduce the severity of illness in people who get vaccinated but still get sick.

Experts also recommend that people get the shot early, because it takes about two weeks after the vaccination for the recipient to develop immunity.

Contrary to a pervasive myth, the flu vaccine cannot give you the flu.

The CDC says "flu vaccines cannot cause flu illness" because the vaccine is made from flu viruses that have been "inactivated" or "killed" and thus are not infectious, or from a single gene from a flu virus, as opposed to the full virus, which allows a person to produce an immune response without getting the infection.

The CDC recommends that everyone over six months of age get a flu vaccination every year, and especially people who may be at higher risk for complications or negative consequences. They include:

• Children age six months through 59 months;
• Women who are or will be pregnant during the flu season;
• Persons 50 years of age or older;
• Persons with extreme obesity (body-mass index of 40 or greater);
• Persons aged six months and older with chronic health problems;
• Residents of nursing homes and other long-term care facilities;
• Household contacts and caregivers of children younger than 5 and adults 50 and older.
• Household contacts and caregivers or people who live with a person at high-risk for complications from the flu; and
• Health care workers, including physicians, nurses, medical emergency-response workers, employees of nursing home and long-term care facilities who have contact with patients or residents, and students in these professions who will have contact with patients.

And don't forget to use common-sense practices: wash your hands frequently, cover your mouth when you cough or sneeze and stay home when you are sick to stop the spread of infection.

If you're looking for a place to get your flu shot, the CDC offers an interactive "flu vaccine finder" that allows you to type in your zip-code to find nearby locations that offer flu shots. Local health departments also offer the vaccine.

Saturday, October 13, 2018

Providers didn't give reason for prescribing opioids 1/3 of the time; study says better documentation could decrease prescribing

An analysis of medical records from 2006 to 2015 found that doctors didn't record a diagnosis for opioid prescriptions almost one-third of the time.

"The findings help support criticism by the Centers for Disease Control and Prevention, the Food and Drug Administration and others that say inappropriate prescribing practices have helped drive the opioid crisis," Maggie Fox reports for NBC News.

Nearly 50,000 Americans died from opioids in 2017, 1,565 of them in Kentucky.

CDC photo
The analysis, published in the Annals of Internal Medicine, used data from the National Ambulatory Medical Care Survey, an annual survey of doctor-office visits.

Because providers can enter up to three diagnosis codes per visit, the researchers limited their sample to visits with two or fewer codes to remove this as a possible reason for not listing pain as a diagnosis.

The study found that opioids were prescribed in nearly 32,000 visits, for cancer-related pain 5 percent of the time and for a non-cancer pain 66 percent of the time.

"No pain diagnosis was recorded at the remaining 28.5 percent of visits in which an opioid was prescribed," says the report. It adds later, "At visits with no pain diagnosis recorded, the most common diagnoses were hypertension, hyperlipidemia [high cholesterol], opioid dependence and ‘other follow-up examination'."

Kentucky has aggressively worked to crack down on prescription-drug abuse, including passing a law in 2017 that limits painkillers to a three-day supply for acute pain, in keeping with the CDC's recommendations. However, the law has a long list of exemptions, and allows a prescriber to override it by documenting a justification.

"Transparently and accurately documenting the justification for opioid therapy is essential to ensure appropriate, safe prescribing; yet, providers currently fall far short of this, particularly when renewing prescriptions," the researchers conclude. "Requiring more robust documentation to show the clinical necessity of opioids—which many insurers already do for novel, costly drugs—could prompt providers to more carefully consider the need for opioids while facilitating efforts to identify inappropriate prescribing."

Friday, October 12, 2018

U of L gets $16.4 million from National Institutes of Health to study impacts of the environment on diabetes and obesity

The University of Louisville has been awarded $16.4 million to study how the environment impacts diabetes and obesity, U of L announced.

"Officials said research will be conducted on how air pollution could be connected to diabetes, and whether the dietary supplement carnosine can protect people from air pollution," reports Lisa Gillespie of WFPL.

Aruni Bhatnagar, director of the U of L Diabetes and Obesity Center, told Gillespie that the funding will also be used to explore diabetes and obesity as it relates to cardiovascular issues.

“Diabetes and obesity are the leading cause of public health problems within the country as well as within the state,” Bhatnagar told Gillespie. “Heart disease is one of the main consequences of diabetes and obesity. In fact, people who have diabetes, about 70 percent of them die from heart disease.”

The National Institutes of Health grant will also fund research around the effects of pollution on stem cell health; how exercise can reduce inflammation; and how the heart talks to blood vessels to increase blood flow during exercise, the university says.